Cargando…

The economic burden of chronic neurological disease

Detalles Bibliográficos
Autores principales:	Wynford-Thomas, R., Robertson, N. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686245/ https://www.ncbi.nlm.nih.gov/pubmed/29038885 http://dx.doi.org/10.1007/s00415-017-8632-7

Ejemplares similares

Long-COVID: neurological manifestations and management
por: Williams, Sioned, et al.
Publicado: (2021)

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

“Navigating the network”: localising the lesion with the advent of lesion network mapping
por: Sheppard, Jack, et al.
Publicado: (2023)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

The gut microbiome: neurological development and disease
por: Miah, Latif, et al.
Publicado: (2022)

Zika virus and neurology: proving cause and effect
por: Massey, T. H., et al.
Publicado: (2016)

Socioeconomic status in neurological disorders: a modifiable risk factor?
por: Hrastelj, J., et al.
Publicado: (2022)

Neurological complications of COVID-19: a preliminary review
por: Pryce-Roberts, A., et al.
Publicado: (2020)

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2
por: Cauchi, M., et al.
Publicado: (2021)

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions
por: Bari, S., et al.
Publicado: (2023)

Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis
por: McLauchlan, D., et al.
Publicado: (2020)

Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis
por: Willis, M. D., et al.
Publicado: (2017)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
por: Al-Ansari, Aseel, et al.
Publicado: (2017)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Sleep disorders in Parkinson’s disease
por: Hawken, Jonathan, et al.
Publicado: (2022)

Why antisense could make sense for neurodegeneration
por: Massey, T. H., et al.
Publicado: (2017)

The consequences of valproate exposure in utero
por: Thomas, Rhys H., et al.
Publicado: (2016)

What can rare variant genetics tell us about cognition and intellectual difficulties?
por: Thomas, Rhys H., et al.
Publicado: (2016)

Medication-overuse headache: causes, consequences and management
por: Massey, Thomas H., et al.
Publicado: (2021)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Restless legs syndrome: causes and consequences
por: Massey, T. H., et al.
Publicado: (2020)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment
por: Hrastelj, J., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Clinical patterns in CADASIL
por: Gailani, G., et al.
Publicado: (2022)

Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms
por: Peall, K. J., et al.
Publicado: (2017)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nmmkue3mhm9lk2l61rst9g15qg